Extended-Release Naltrexone Opioid Treatment at Jail-to-Community Re-entry

监狱重返社区时的缓释纳曲酮阿片类药物治疗

基本信息

  • 批准号:
    8438049
  • 负责人:
  • 金额:
    $ 62.87万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2013
  • 资助国家:
    美国
  • 起止时间:
    2013-06-01 至 2018-05-31
  • 项目状态:
    已结题

项目摘要

This study seeks to estimate the effectiveness of newly FDA-approved extended-release naltrexone (XR-NTX) for opioid relapse prevention among opioid dependent participants leaving a large urban jail. While methadone treatment is available in NYC jails, many heroin and other opioid users, including HIV and Hepatitis C (HCV) infected individuals, decline this treatment at arrest, and instead leave jail out-of-treatment and at extraordinarily high risk for immediate opioid relapse, fatal overdose, and HIV/HCV-related adverse outcomes, including resuming patterns of injection drug use and unsafe sex. XR-NTX, an injectable non-narcotic opioid antagonist with no abuse potential, which blocks the usual physiologic effects of heroin and other opioids for up to 4 weeks, constitutes a new pharmacotherapy option for individuals not opting for agonist medications. We propose a randomized trial of XR-NTX versus enhanced treatment-as-usual to establish XR-NTX¿s effectiveness as re-entry opioid relapse and HIV/HCV risk prevention. Further, an important question is how XR-NTX compares to methadone maintenance standard-of-care, and this study will recruit an additional, non-randomized, quasi-experimental methadone cohort for comparative effectiveness purposes.
本研究旨在评估fda新批准的缓释纳曲酮(XR-NTX)在离开大型城市监狱的阿片类药物依赖参与者中预防阿片类药物复发的有效性。虽然纽约市的监狱可以提供美沙酮治疗,但许多海洛因和其他阿片类药物使用者,包括感染艾滋病毒和丙型肝炎(HCV)的人,在被捕时拒绝接受这种治疗,而是离开监狱后得不到治疗,并且面临着立即发生阿片类药物复发、致命过量和与艾滋病毒/丙型肝炎相关的不良后果的极高风险,包括恢复注射吸毒和不安全性行为的模式。XR-NTX是一种可注射的非麻醉性阿片类拮抗剂,没有滥用的可能性,可阻断海洛因和其他阿片类药物通常的生理作用长达4周,对于不选择激动剂药物的个人来说,这是一种新的药物治疗选择。我们建议进行XR-NTX与常规强化治疗的随机试验,以确定XR-NTX在阿片类药物复发和HIV/HCV风险预防方面的有效性。此外,一个重要的问题是XR-NTX与美沙酮维持标准护理的比较,本研究将招募一个额外的、非随机的、准实验的美沙酮队列,以比较有效性。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

JOSHUA D LEE其他文献

JOSHUA D LEE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('JOSHUA D LEE', 18)}}的其他基金

Impact of Jail-Based Methadone on Overdose, Recidivism, HIV and Health Outcomes, and Costs in New York City, 2011-2017
2011-2017 年纽约市监狱美沙酮对用药过量、累犯、艾滋病毒和健康结果及成本的影响
  • 批准号:
    9759907
  • 财政年份:
    2018
  • 资助金额:
    $ 62.87万
  • 项目类别:
Impact of Jail-Based Methadone on Overdose, Recidivism, HIV and Health Outcomes, and Costs in New York City, 2011-2017
2011-2017 年纽约市监狱美沙酮对用药过量、累犯、艾滋病毒和健康结果及成本的影响
  • 批准号:
    10152575
  • 财政年份:
    2018
  • 资助金额:
    $ 62.87万
  • 项目类别:
Impact of Jail-Based Methadone on Overdose, Recidivism, HIV and Health Outcomes, and Costs in New York City, 2011-2017
2011-2017 年纽约市监狱美沙酮对用药过量、累犯、艾滋病毒和健康结果及成本的影响
  • 批准号:
    10407967
  • 财政年份:
    2018
  • 资助金额:
    $ 62.87万
  • 项目类别:
Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care
初级保健中的缓释与口服纳曲酮酒精治疗
  • 批准号:
    9258373
  • 财政年份:
    2013
  • 资助金额:
    $ 62.87万
  • 项目类别:
Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care
初级保健中的缓释与口服纳曲酮酒精治疗
  • 批准号:
    9058442
  • 财政年份:
    2013
  • 资助金额:
    $ 62.87万
  • 项目类别:
Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care
初级保健中的缓释与口服纳曲酮酒精治疗
  • 批准号:
    8842053
  • 财政年份:
    2013
  • 资助金额:
    $ 62.87万
  • 项目类别:
Extended-Release Naltrexone Opioid Treatment at Jail-to-Community Re-entry
监狱重返社区时的缓释纳曲酮阿片类药物治疗
  • 批准号:
    8664355
  • 财政年份:
    2013
  • 资助金额:
    $ 62.87万
  • 项目类别:
Treatment Study Using Depot Naltrexone (3/6) NY/Bellevue Protocol Treatment Site
使用长效纳曲酮 (3/6) 纽约/贝尔维尤方案治疗站点的治疗研究
  • 批准号:
    8671607
  • 财政年份:
    2013
  • 资助金额:
    $ 62.87万
  • 项目类别:
Extended-Release vs. Oral Naltrexone Alcohol Treatment in Primary Care
初级保健中的缓释与口服纳曲酮酒精治疗
  • 批准号:
    8703579
  • 财政年份:
    2013
  • 资助金额:
    $ 62.87万
  • 项目类别:
Extended-Release Naltrexone Opioid Treatment at Jail-to-Community Re-entry
监狱重返社区时的缓释纳曲酮阿片类药物治疗
  • 批准号:
    9275947
  • 财政年份:
    2013
  • 资助金额:
    $ 62.87万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 62.87万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 62.87万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 62.87万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了